These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9691224)

  • 41. Proteolytic activity in vivo and encapsidation of recombinant human immunodeficiency virus type 1 proteinase expressed in baculovirus-infected cells.
    Royer M; Bardy M; Gay B; Tournier J; Boulanger P
    J Gen Virol; 1997 Jan; 78 ( Pt 1)():131-42. PubMed ID: 9010296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.
    Kaplan AH; Swanstrom R
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4528-32. PubMed ID: 2034693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.
    Hill MK; Hooker CW; Harrich D; Crowe SM; Mak J
    J Virol; 2001 Aug; 75(15):6835-40. PubMed ID: 11435562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278).
    Kelly BN; Howard BR; Wang H; Robinson H; Sundquist WI; Hill CP
    Biochemistry; 2006 Sep; 45(38):11257-66. PubMed ID: 16981686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.
    Schubert U; Ott DE; Chertova EN; Welker R; Tessmer U; Princiotta MF; Bennink JR; Krausslich HG; Yewdell JW
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13057-62. PubMed ID: 11087859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants.
    Chen YL; Ts'ai PW; Yang CC; Wang CT
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2497-501. PubMed ID: 9349470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
    Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
    J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Structure of Immature Virus-Like Rous Sarcoma Virus Gag Particles Reveals a Structural Role for the p10 Domain in Assembly.
    Schur FK; Dick RA; Hagen WJ; Vogt VM; Briggs JA
    J Virol; 2015 Oct; 89(20):10294-302. PubMed ID: 26223638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization.
    Kafaie J; Dolatshahi M; Ajamian L; Song R; Mouland AJ; Rouiller I; Laughrea M
    Virology; 2009 Mar; 385(1):233-44. PubMed ID: 19070880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.
    Huang L; Sayer JM; Swinford M; Louis JM; Chen C
    J Virol; 2009 Aug; 83(15):7789-93. PubMed ID: 19457992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors.
    Tien C; Huang L; Watanabe SM; Speidel JT; Carter CA; Chen C
    PLoS One; 2018; 13(1):e0191372. PubMed ID: 29338056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication.
    Kaplan AH; Manchester M; Smith T; Yang YL; Swanstrom R
    J Virol; 1996 Sep; 70(9):5840-4. PubMed ID: 8709202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding HIV-1 protease autoprocessing for novel therapeutic development.
    Huang L; Chen C
    Future Med Chem; 2013 Jul; 5(11):1215-29. PubMed ID: 23859204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.
    Pan YY; Wang SM; Huang KJ; Chiang CC; Wang CT
    PLoS One; 2012; 7(3):e32845. PubMed ID: 22396796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutational analysis of a native substrate of the HIV-1 proteinase.
    Partin K; Wimmer E; Carter C
    Adv Exp Med Biol; 1991; 306():503-6. PubMed ID: 1667451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Single Amino Acid Substitution at the HIV-1 Protease Termini Dimer Interface Significantly Reduces Viral Particles Processing Efficiency.
    Chiang M; Wang C
    Jpn J Infect Dis; 2021 Jul; 74(4):299-306. PubMed ID: 33390426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.